A month has gone by since the last earnings report for Cabot (CBT) . Shares have added about 0.9% in that time frame, underperforming the S&P 500.But investors have to be wondering, will the recent positive trend continue leading up to its next earnings release, or is Cabot due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its most recent earnings report in order to get a better handle on the important catalysts.Cabot's Earnings Top Estima ...

Group 1 - Compass Minerals reported a quarterly loss of $0.39 per share, which was worse than the Zacks Consensus Estimate of a loss of $0.13, but an improvement from a loss of $1.01 per share a year ago, indicating a significant earnings surprise of -200.00% [1] - The company posted revenues of $214.6 million for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 2.89% and showing an increase from $202.9 million in the same quarter last year [2] - Compass has outperformed the S&P 500, with its shares gaining about 90.6% since the beginning of the year compared to the S&P 500's gain of 8.6% [3] Group 2 - The earnings outlook for Compass is crucial for investors, as it includes current consensus earnings expectations for upcoming quarters and any recent changes to these expectations [4] - The trend of estimate revisions for Compass was favorable ahead of the earnings release, resulting in a Zacks Rank 2 (Buy) for the stock, indicating expected outperformance in the near future [6] - The current consensus EPS estimate for the upcoming quarter is -$0.16 on revenues of $212.26 million, and for the current fiscal year, it is -$0.40 on revenues of $1.23 billion [7] Group 3 - The Chemical - Diversified industry, to which Compass belongs, is currently in the bottom 9% of over 250 Zacks industries, suggesting that the industry outlook could materially impact the stock's performance [8]

Core Viewpoint - Koppers reported quarterly earnings of $1.48 per share, slightly missing the Zacks Consensus Estimate of $1.49 per share, but showing an increase from $1.36 per share a year ago [1][2] Financial Performance - The earnings surprise for the quarter was -0.67%, while the previous quarter saw a positive surprise of +26.79% with actual earnings of $0.71 per share against an expectation of $0.56 [2] - Koppers' revenues for the quarter ended June 2025 were $504.8 million, missing the Zacks Consensus Estimate by 9.42%, and down from $563.2 million year-over-year [3] Stock Performance - Koppers shares have increased approximately 2.7% since the beginning of the year, compared to a 7.8% gain in the S&P 500 [4] - The current Zacks Rank for Koppers is 3 (Hold), indicating expected performance in line with the market in the near future [7] Future Outlook - The consensus EPS estimate for the upcoming quarter is $1.58 on revenues of $549.7 million, and for the current fiscal year, it is $4.61 on revenues of $2.02 billion [8] - The outlook for the Chemical - Diversified industry, to which Koppers belongs, is currently in the bottom 7% of over 250 Zacks industries, which may impact stock performance [9]

Company Performance - Kronos Worldwide reported a quarterly loss of $0.08 per share, missing the Zacks Consensus Estimate of $0.13, and down from earnings of $0.17 per share a year ago, representing an earnings surprise of -161.54% [1] - The company posted revenues of $494.4 million for the quarter ended June 2025, missing the Zacks Consensus Estimate by 1.32%, and down from $500.5 million in the same quarter last year [2] - Over the last four quarters, Kronos Worldwide has surpassed consensus EPS estimates only once and has topped consensus revenue estimates just once [2] Stock Performance - Kronos Worldwide shares have declined approximately 43.6% since the beginning of the year, contrasting with the S&P 500's gain of 7.1% [3] - The current Zacks Rank for Kronos Worldwide is 4 (Sell), indicating expectations of underperformance in the near future [6] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $0.14 on revenues of $484.36 million, and for the current fiscal year, it is $0.53 on revenues of $1.9 billion [7] - The trend of estimate revisions for Kronos Worldwide was unfavorable prior to the earnings release, which may impact future stock movements [5][6] Industry Context - The Chemical - Diversified industry, to which Kronos Worldwide belongs, is currently ranked in the bottom 7% of over 250 Zacks industries, suggesting a challenging environment [8]

Core Viewpoint - Chemours reported quarterly earnings of $0.58 per share, exceeding the Zacks Consensus Estimate of $0.46 per share, and showing an increase from $0.38 per share a year ago, indicating a strong earnings surprise of +26.09% [1] Group 1: Earnings Performance - The company has surpassed consensus EPS estimates three times over the last four quarters [2] - Chemours posted revenues of $1.62 billion for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 2.98%, compared to $1.54 billion in the same quarter last year [2] - The earnings report reflects a significant improvement in earnings performance compared to the previous quarter, where the expected earnings were $0.19 per share, but the actual was $0.13, resulting in a surprise of -31.58% [1][2] Group 2: Stock Performance and Outlook - Chemours shares have declined approximately 27.8% since the beginning of the year, contrasting with the S&P 500's gain of 7.6% [3] - The company's earnings outlook is crucial for assessing future stock performance, with current consensus EPS estimates at $0.50 for the coming quarter and $1.47 for the current fiscal year [4][7] - The Zacks Rank for Chemours is currently 5 (Strong Sell), indicating expectations of underperformance in the near future [6] Group 3: Industry Context - The Chemical - Diversified industry, to which Chemours belongs, is currently ranked in the bottom 7% of over 250 Zacks industries, suggesting a challenging environment for stock performance [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can impact Chemours' stock performance [5]

Innospec (IOSP) came out with quarterly earnings of $1.26 per share, beating the Zacks Consensus Estimate of $1.17 per share. This compares to earnings of $1.39 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +7.69%. A quarter ago, it was expected that this specialty chemicals company would post earnings of $1.4 per share when it actually produced earnings of $1.42, delivering a surprise of +1.43%.Over the last four quarters, ...

DuPont de Nemours (DD) came out with quarterly earnings of $1.12 per share, beating the Zacks Consensus Estimate of $1.06 per share. This compares to earnings of $0.97 per share a year ago. These figures are adjusted for non-recurring items. There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations ...

Core Insights - Cabot (CBT) reported quarterly earnings of $1.9 per share, exceeding the Zacks Consensus Estimate of $1.8 per share, but down from $1.92 per share a year ago, indicating a slight year-over-year decline [1] - The company posted revenues of $923 million for the quarter ended June 2025, missing the Zacks Consensus Estimate by 4.09% and down from $1.02 billion year-over-year [2] - Cabot shares have declined approximately 21.2% year-to-date, contrasting with the S&P 500's gain of 6.1% [3] Earnings Performance - Over the last four quarters, Cabot has surpassed consensus EPS estimates two times [2] - The recent earnings surprise of +5.56% indicates a positive deviation from expectations, while the previous quarter's surprise was +2.15% [1][2] Future Outlook - The current consensus EPS estimate for the upcoming quarter is $1.79, with projected revenues of $984.79 million, and for the current fiscal year, the EPS estimate is $7.25 on revenues of $3.83 billion [7] - The estimate revisions trend for Cabot was unfavorable prior to the earnings release, resulting in a Zacks Rank 4 (Sell) for the stock, suggesting expected underperformance in the near future [6] Industry Context - The Chemical - Diversified industry, to which Cabot belongs, is currently ranked in the bottom 6% of over 250 Zacks industries, indicating a challenging environment [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which could impact Cabot's stock performance [5]

Group 1 - Compass Minerals (CMP) has significantly outperformed its peers in the Basic Materials sector, returning approximately 77.2% year-to-date compared to the sector average of 8.8% [4] - The Zacks Rank for Compass Minerals is currently 2 (Buy), indicating a positive outlook based on earnings estimates and revisions, with a 25% increase in the consensus estimate for full-year earnings over the past quarter [3] - Compass Minerals is part of the Chemical - Diversified industry, which has seen an average loss of 16.8% this year, further highlighting CMP's strong performance relative to its industry [5] Group 2 - The Basic Materials sector includes 238 individual stocks and holds a Zacks Sector Rank of 12 among 16 sector groups, indicating a relatively lower performance compared to other sectors [2] - Posco (PKX), another stock in the Basic Materials sector, has also outperformed with a year-to-date return of 26%, and it currently holds a Zacks Rank of 2 (Buy) [4][5] - The Steel - Producers industry, to which Posco belongs, has a year-to-date gain of 18.4%, ranking 208 among industries, which is lower than the performance of Compass Minerals [6]

分组1 - LyondellBasell reported quarterly earnings of $0.62 per share, missing the Zacks Consensus Estimate of $0.87 per share, and down from $2.24 per share a year ago, representing an earnings surprise of -28.74% [1] - The company posted revenues of $7.66 billion for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 3.41%, but down from $10.56 billion year-over-year [2] - LyondellBasell shares have declined approximately 22% since the beginning of the year, contrasting with the S&P 500's gain of 7.8% [3] 分组2 - The current consensus EPS estimate for the upcoming quarter is $1.16 on revenues of $7.34 billion, and for the current fiscal year, it is $3.50 on revenues of $29.79 billion [7] - The Zacks Industry Rank for Chemical - Diversified is currently in the bottom 5% of over 250 Zacks industries, indicating a challenging environment for the sector [8] - The estimate revisions trend for LyondellBasell was unfavorable ahead of the earnings release, resulting in a Zacks Rank 5 (Strong Sell) for the stock [6]